Eintrag weiter verarbeiten
Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017
Gespeichert in:
| Zeitschriftentitel: | Journal of Clinical Laboratory Analysis |
|---|---|
| Personen und Körperschaften: | , , , , , , , |
| In: | Journal of Clinical Laboratory Analysis, 33, 2019, 1 |
| Format: | E-Article |
| Sprache: | Englisch |
| veröffentlicht: |
Wiley
|
| Schlagwörter: |
| author_facet |
Sun, Huizhen Wang, Wei Zhao, Haijian Zhang, Chuanbao He, Falin Zhong, Kun Yuan, Shuai Wang, Zhiguo Sun, Huizhen Wang, Wei Zhao, Haijian Zhang, Chuanbao He, Falin Zhong, Kun Yuan, Shuai Wang, Zhiguo |
|---|---|
| author |
Sun, Huizhen Wang, Wei Zhao, Haijian Zhang, Chuanbao He, Falin Zhong, Kun Yuan, Shuai Wang, Zhiguo |
| spellingShingle |
Sun, Huizhen Wang, Wei Zhao, Haijian Zhang, Chuanbao He, Falin Zhong, Kun Yuan, Shuai Wang, Zhiguo Journal of Clinical Laboratory Analysis Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 Microbiology (medical) Biochemistry (medical) Medical Laboratory Technology Clinical Biochemistry Public Health, Environmental and Occupational Health Hematology Immunology and Allergy |
| author_sort |
sun, huizhen |
| spelling |
Sun, Huizhen Wang, Wei Zhao, Haijian Zhang, Chuanbao He, Falin Zhong, Kun Yuan, Shuai Wang, Zhiguo 0887-8013 1098-2825 Wiley Microbiology (medical) Biochemistry (medical) Medical Laboratory Technology Clinical Biochemistry Public Health, Environmental and Occupational Health Hematology Immunology and Allergy http://dx.doi.org/10.1002/jcla.22643 <jats:sec><jats:title>Background</jats:title><jats:p>This study aimed to investigate and analyze the status of internal quality control (<jats:styled-content style="fixed-case">IQC</jats:styled-content>) for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> from 2014 to 2017, so as to have an integral understanding of quality performance of measurement in clinical laboratories in China.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The 4‐year <jats:styled-content style="fixed-case">IQC</jats:styled-content> information for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> of participant laboratories were collected through <jats:styled-content style="fixed-case">EQA</jats:styled-content> reporting system. Percentages of laboratories meeting different quality requirements (pass rates) for current coefficient of variations (<jats:styled-content style="fixed-case">CV</jats:styled-content>s) were calculated afterwards. Further analysis for current <jats:styled-content style="fixed-case">CV</jats:styled-content>s and pass rates among different years and measurement systems were conducted. Finally, we analyzed and summarized <jats:styled-content style="fixed-case">IQC</jats:styled-content> practice and its changes in 4 years.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The current <jats:styled-content style="fixed-case">CV</jats:styled-content>s for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> have decreased significantly from 2014 to 2017, and pass rates both presented significant increasing trends. <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> had higher pass rates than <jats:styled-content style="fixed-case">BNP</jats:styled-content> regardless of 1/3<jats:styled-content style="fixed-case">TE</jats:styled-content>a or 1/4<jats:styled-content style="fixed-case">TE</jats:styled-content>a specification was used. The main measurement systems for two analytes were different. For <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content>, current <jats:styled-content style="fixed-case">CV</jats:styled-content>s of Roche has decreased significantly among 4 years and were significantly lower than Radiometer and BioMérieux in 2015. Current <jats:styled-content style="fixed-case">CV</jats:styled-content>s of Abbott also had decreasing tendency for <jats:styled-content style="fixed-case">BNP</jats:styled-content>. Analysis of <jats:styled-content style="fixed-case">IQC</jats:styled-content> practice indicated that control rules and <jats:styled-content style="fixed-case">IQC</jats:styled-content> frequency had made great progress in 4 years.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The imprecision performance of measurement of <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> has improved with decreasing of current <jats:styled-content style="fixed-case">CV</jats:styled-content>s and increasing of pass rates in 4 years. However, it still needs continual improvement. Clinical laboratories in China should take active actions to promote performance of <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> measurement.</jats:p></jats:sec> Internal quality control status for <scp>BNP</scp> and <scp>NT</scp>‐pro<scp>BNP</scp> in China from 2014 to 2017 Journal of Clinical Laboratory Analysis |
| doi_str_mv |
10.1002/jcla.22643 |
| facet_avail |
Online Free |
| finc_class_facet |
Medizin Technik Chemie und Pharmazie Biologie |
| format |
ElectronicArticle |
| fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9qY2xhLjIyNjQz |
| id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9qY2xhLjIyNjQz |
| institution |
DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-D161 DE-Zwi2 |
| imprint |
Wiley, 2019 |
| imprint_str_mv |
Wiley, 2019 |
| issn |
0887-8013 1098-2825 |
| issn_str_mv |
0887-8013 1098-2825 |
| language |
English |
| mega_collection |
Wiley (CrossRef) |
| match_str |
sun2019internalqualitycontrolstatusforbnpandntprobnpinchinafrom2014to2017 |
| publishDateSort |
2019 |
| publisher |
Wiley |
| recordtype |
ai |
| record_format |
ai |
| series |
Journal of Clinical Laboratory Analysis |
| source_id |
49 |
| title |
Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_unstemmed |
Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_full |
Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_fullStr |
Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_full_unstemmed |
Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_short |
Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_sort |
internal quality control status for <scp>bnp</scp> and <scp>nt</scp>‐pro<scp>bnp</scp> in china from 2014 to 2017 |
| topic |
Microbiology (medical) Biochemistry (medical) Medical Laboratory Technology Clinical Biochemistry Public Health, Environmental and Occupational Health Hematology Immunology and Allergy |
| url |
http://dx.doi.org/10.1002/jcla.22643 |
| publishDate |
2019 |
| physical |
|
| description |
<jats:sec><jats:title>Background</jats:title><jats:p>This study aimed to investigate and analyze the status of internal quality control (<jats:styled-content style="fixed-case">IQC</jats:styled-content>) for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> from 2014 to 2017, so as to have an integral understanding of quality performance of measurement in clinical laboratories in China.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The 4‐year <jats:styled-content style="fixed-case">IQC</jats:styled-content> information for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> of participant laboratories were collected through <jats:styled-content style="fixed-case">EQA</jats:styled-content> reporting system. Percentages of laboratories meeting different quality requirements (pass rates) for current coefficient of variations (<jats:styled-content style="fixed-case">CV</jats:styled-content>s) were calculated afterwards. Further analysis for current <jats:styled-content style="fixed-case">CV</jats:styled-content>s and pass rates among different years and measurement systems were conducted. Finally, we analyzed and summarized <jats:styled-content style="fixed-case">IQC</jats:styled-content> practice and its changes in 4 years.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The current <jats:styled-content style="fixed-case">CV</jats:styled-content>s for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> have decreased significantly from 2014 to 2017, and pass rates both presented significant increasing trends. <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> had higher pass rates than <jats:styled-content style="fixed-case">BNP</jats:styled-content> regardless of 1/3<jats:styled-content style="fixed-case">TE</jats:styled-content>a or 1/4<jats:styled-content style="fixed-case">TE</jats:styled-content>a specification was used. The main measurement systems for two analytes were different. For <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content>, current <jats:styled-content style="fixed-case">CV</jats:styled-content>s of Roche has decreased significantly among 4 years and were significantly lower than Radiometer and BioMérieux in 2015. Current <jats:styled-content style="fixed-case">CV</jats:styled-content>s of Abbott also had decreasing tendency for <jats:styled-content style="fixed-case">BNP</jats:styled-content>. Analysis of <jats:styled-content style="fixed-case">IQC</jats:styled-content> practice indicated that control rules and <jats:styled-content style="fixed-case">IQC</jats:styled-content> frequency had made great progress in 4 years.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The imprecision performance of measurement of <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> has improved with decreasing of current <jats:styled-content style="fixed-case">CV</jats:styled-content>s and increasing of pass rates in 4 years. However, it still needs continual improvement. Clinical laboratories in China should take active actions to promote performance of <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> measurement.</jats:p></jats:sec> |
| container_issue |
1 |
| container_start_page |
0 |
| container_title |
Journal of Clinical Laboratory Analysis |
| container_volume |
33 |
| format_de105 |
Article, E-Article |
| format_de14 |
Article, E-Article |
| format_de15 |
Article, E-Article |
| format_de520 |
Article, E-Article |
| format_de540 |
Article, E-Article |
| format_dech1 |
Article, E-Article |
| format_ded117 |
Article, E-Article |
| format_degla1 |
E-Article |
| format_del152 |
Buch |
| format_del189 |
Article, E-Article |
| format_dezi4 |
Article |
| format_dezwi2 |
Article, E-Article |
| format_finc |
Article, E-Article |
| format_nrw |
Article, E-Article |
| _version_ |
1792336520795914249 |
| geogr_code |
not assigned |
| last_indexed |
2024-03-01T15:01:44.626Z |
| geogr_code_person |
not assigned |
| openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Internal+quality+control+status+for+BNP+and+NT%E2%80%90proBNP+in+China+from+2014+to+2017&rft.date=2019-01-01&genre=article&issn=1098-2825&volume=33&issue=1&jtitle=Journal+of+Clinical+Laboratory+Analysis&atitle=Internal+quality+control+status+for+%3Cscp%3EBNP%3C%2Fscp%3E+and+%3Cscp%3ENT%3C%2Fscp%3E%E2%80%90pro%3Cscp%3EBNP%3C%2Fscp%3E+in+China+from+2014+to+2017&aulast=Wang&aufirst=Zhiguo&rft_id=info%3Adoi%2F10.1002%2Fjcla.22643&rft.language%5B0%5D=eng |
| SOLR | |
| _version_ | 1792336520795914249 |
| author | Sun, Huizhen, Wang, Wei, Zhao, Haijian, Zhang, Chuanbao, He, Falin, Zhong, Kun, Yuan, Shuai, Wang, Zhiguo |
| author_facet | Sun, Huizhen, Wang, Wei, Zhao, Haijian, Zhang, Chuanbao, He, Falin, Zhong, Kun, Yuan, Shuai, Wang, Zhiguo, Sun, Huizhen, Wang, Wei, Zhao, Haijian, Zhang, Chuanbao, He, Falin, Zhong, Kun, Yuan, Shuai, Wang, Zhiguo |
| author_sort | sun, huizhen |
| container_issue | 1 |
| container_start_page | 0 |
| container_title | Journal of Clinical Laboratory Analysis |
| container_volume | 33 |
| description | <jats:sec><jats:title>Background</jats:title><jats:p>This study aimed to investigate and analyze the status of internal quality control (<jats:styled-content style="fixed-case">IQC</jats:styled-content>) for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> from 2014 to 2017, so as to have an integral understanding of quality performance of measurement in clinical laboratories in China.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The 4‐year <jats:styled-content style="fixed-case">IQC</jats:styled-content> information for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> of participant laboratories were collected through <jats:styled-content style="fixed-case">EQA</jats:styled-content> reporting system. Percentages of laboratories meeting different quality requirements (pass rates) for current coefficient of variations (<jats:styled-content style="fixed-case">CV</jats:styled-content>s) were calculated afterwards. Further analysis for current <jats:styled-content style="fixed-case">CV</jats:styled-content>s and pass rates among different years and measurement systems were conducted. Finally, we analyzed and summarized <jats:styled-content style="fixed-case">IQC</jats:styled-content> practice and its changes in 4 years.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The current <jats:styled-content style="fixed-case">CV</jats:styled-content>s for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> have decreased significantly from 2014 to 2017, and pass rates both presented significant increasing trends. <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> had higher pass rates than <jats:styled-content style="fixed-case">BNP</jats:styled-content> regardless of 1/3<jats:styled-content style="fixed-case">TE</jats:styled-content>a or 1/4<jats:styled-content style="fixed-case">TE</jats:styled-content>a specification was used. The main measurement systems for two analytes were different. For <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content>, current <jats:styled-content style="fixed-case">CV</jats:styled-content>s of Roche has decreased significantly among 4 years and were significantly lower than Radiometer and BioMérieux in 2015. Current <jats:styled-content style="fixed-case">CV</jats:styled-content>s of Abbott also had decreasing tendency for <jats:styled-content style="fixed-case">BNP</jats:styled-content>. Analysis of <jats:styled-content style="fixed-case">IQC</jats:styled-content> practice indicated that control rules and <jats:styled-content style="fixed-case">IQC</jats:styled-content> frequency had made great progress in 4 years.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The imprecision performance of measurement of <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> has improved with decreasing of current <jats:styled-content style="fixed-case">CV</jats:styled-content>s and increasing of pass rates in 4 years. However, it still needs continual improvement. Clinical laboratories in China should take active actions to promote performance of <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> measurement.</jats:p></jats:sec> |
| doi_str_mv | 10.1002/jcla.22643 |
| facet_avail | Online, Free |
| finc_class_facet | Medizin, Technik, Chemie und Pharmazie, Biologie |
| format | ElectronicArticle |
| format_de105 | Article, E-Article |
| format_de14 | Article, E-Article |
| format_de15 | Article, E-Article |
| format_de520 | Article, E-Article |
| format_de540 | Article, E-Article |
| format_dech1 | Article, E-Article |
| format_ded117 | Article, E-Article |
| format_degla1 | E-Article |
| format_del152 | Buch |
| format_del189 | Article, E-Article |
| format_dezi4 | Article |
| format_dezwi2 | Article, E-Article |
| format_finc | Article, E-Article |
| format_nrw | Article, E-Article |
| geogr_code | not assigned |
| geogr_code_person | not assigned |
| id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAwMi9qY2xhLjIyNjQz |
| imprint | Wiley, 2019 |
| imprint_str_mv | Wiley, 2019 |
| institution | DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-D161, DE-Zwi2 |
| issn | 0887-8013, 1098-2825 |
| issn_str_mv | 0887-8013, 1098-2825 |
| language | English |
| last_indexed | 2024-03-01T15:01:44.626Z |
| match_str | sun2019internalqualitycontrolstatusforbnpandntprobnpinchinafrom2014to2017 |
| mega_collection | Wiley (CrossRef) |
| physical | |
| publishDate | 2019 |
| publishDateSort | 2019 |
| publisher | Wiley |
| record_format | ai |
| recordtype | ai |
| series | Journal of Clinical Laboratory Analysis |
| source_id | 49 |
| spelling | Sun, Huizhen Wang, Wei Zhao, Haijian Zhang, Chuanbao He, Falin Zhong, Kun Yuan, Shuai Wang, Zhiguo 0887-8013 1098-2825 Wiley Microbiology (medical) Biochemistry (medical) Medical Laboratory Technology Clinical Biochemistry Public Health, Environmental and Occupational Health Hematology Immunology and Allergy http://dx.doi.org/10.1002/jcla.22643 <jats:sec><jats:title>Background</jats:title><jats:p>This study aimed to investigate and analyze the status of internal quality control (<jats:styled-content style="fixed-case">IQC</jats:styled-content>) for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> from 2014 to 2017, so as to have an integral understanding of quality performance of measurement in clinical laboratories in China.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>The 4‐year <jats:styled-content style="fixed-case">IQC</jats:styled-content> information for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> of participant laboratories were collected through <jats:styled-content style="fixed-case">EQA</jats:styled-content> reporting system. Percentages of laboratories meeting different quality requirements (pass rates) for current coefficient of variations (<jats:styled-content style="fixed-case">CV</jats:styled-content>s) were calculated afterwards. Further analysis for current <jats:styled-content style="fixed-case">CV</jats:styled-content>s and pass rates among different years and measurement systems were conducted. Finally, we analyzed and summarized <jats:styled-content style="fixed-case">IQC</jats:styled-content> practice and its changes in 4 years.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>The current <jats:styled-content style="fixed-case">CV</jats:styled-content>s for <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> have decreased significantly from 2014 to 2017, and pass rates both presented significant increasing trends. <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> had higher pass rates than <jats:styled-content style="fixed-case">BNP</jats:styled-content> regardless of 1/3<jats:styled-content style="fixed-case">TE</jats:styled-content>a or 1/4<jats:styled-content style="fixed-case">TE</jats:styled-content>a specification was used. The main measurement systems for two analytes were different. For <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content>, current <jats:styled-content style="fixed-case">CV</jats:styled-content>s of Roche has decreased significantly among 4 years and were significantly lower than Radiometer and BioMérieux in 2015. Current <jats:styled-content style="fixed-case">CV</jats:styled-content>s of Abbott also had decreasing tendency for <jats:styled-content style="fixed-case">BNP</jats:styled-content>. Analysis of <jats:styled-content style="fixed-case">IQC</jats:styled-content> practice indicated that control rules and <jats:styled-content style="fixed-case">IQC</jats:styled-content> frequency had made great progress in 4 years.</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>The imprecision performance of measurement of <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> has improved with decreasing of current <jats:styled-content style="fixed-case">CV</jats:styled-content>s and increasing of pass rates in 4 years. However, it still needs continual improvement. Clinical laboratories in China should take active actions to promote performance of <jats:styled-content style="fixed-case">BNP</jats:styled-content> and <jats:styled-content style="fixed-case">NT</jats:styled-content>‐pro<jats:styled-content style="fixed-case">BNP</jats:styled-content> measurement.</jats:p></jats:sec> Internal quality control status for <scp>BNP</scp> and <scp>NT</scp>‐pro<scp>BNP</scp> in China from 2014 to 2017 Journal of Clinical Laboratory Analysis |
| spellingShingle | Sun, Huizhen, Wang, Wei, Zhao, Haijian, Zhang, Chuanbao, He, Falin, Zhong, Kun, Yuan, Shuai, Wang, Zhiguo, Journal of Clinical Laboratory Analysis, Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017, Microbiology (medical), Biochemistry (medical), Medical Laboratory Technology, Clinical Biochemistry, Public Health, Environmental and Occupational Health, Hematology, Immunology and Allergy |
| title | Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_full | Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_fullStr | Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_full_unstemmed | Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_short | Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| title_sort | internal quality control status for <scp>bnp</scp> and <scp>nt</scp>‐pro<scp>bnp</scp> in china from 2014 to 2017 |
| title_unstemmed | Internal quality control status for BNP and NT‐proBNP in China from 2014 to 2017 |
| topic | Microbiology (medical), Biochemistry (medical), Medical Laboratory Technology, Clinical Biochemistry, Public Health, Environmental and Occupational Health, Hematology, Immunology and Allergy |
| url | http://dx.doi.org/10.1002/jcla.22643 |